drugset / Trial / NCT02821520

Initial Versus Delayed PDT Combination With Conbercept in PCV

NCT02821520 ↗

Phase 4 Completed 80 enrolled The Eye Hospital of Wenzhou Medical University
RandomizedParallel-groupOpen-labelTreatment

Summary

To compare the initial versus delayed verteporfin photodynamic therapy (PDT) in combination with conbercept in patients with symptomatic polypoidal choroidal vasculopathy (PCV).

Timeline

Start
2017-01
Primary completion
2019-06
Completion
2019-06

Outcome

Met primary endpoint

paper [delayed group minus initial group: 1.07 letters; 95% confidence interval (CI): -4.62 to 6.76; P non-inferiority = 0.0198]. PMID 35223882 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Conbercept Protein / enzyme biologic 0.5 mg Intravitreal

Indications

No indication recorded.